期刊文献+

心脏再同步治疗对慢性心力衰竭病人右心室功能和炎症因子水平的影响 被引量:4

Effect of Cardiac Resynchronization Therapy on Right Ventricular Function and Inflammatory Factors in Patients with Chronic Heart Failure
下载PDF
导出
摘要 目的观察心脏再同步治疗(CRT)对慢性心力衰竭病人右心室功能和炎症因子水平的影响。方法选取2014年6月—2017年6月在我院接受脏再同步治疗的86例中重度慢性心力衰竭病人,随访6个月。以纽约心脏病协会(NYHA)心功能分级下降1级及以上,且左心室收缩末期容积降低15%以上的病人为观察组,剩余病人为对照组。结果心脏功能指标:术后观察组病人左室舒张末期容积(LVEDV)、左室收缩末期容积(LVESV)、左室射血分数(LVEF)、右室心肌功能指数(RIMP)评分均较术前降低(P <0.05),右室面积变化率(RVFAC)、三尖瓣环收缩期位移(TAPSE)、收缩期右心室侧壁三尖瓣环运动速度(Vsr)及E峰则延长或提高(P <0.05)。对照组各项心脏功能指标和术前比较差异无统计学意义(P>0.05)。与术前比较,观察组术后Tei指数降低,对照组术后Tei指数升高(P <0.05)。炎症指标显示,术后6个月,两组炎症因子表达水平均不同程度降低,观察组术后TNF-α、IL-6、hs-CRP与术前比较差异有统计学意义(P <0.05),而对照组术后TNF-α、IL-6、hs-CRP与术前比较差异无统计学意义(P>0.05)。观察组术后TNF-α、IL-6、hs-CRP表达水平低于对照组(P <0.05)。观察组生活质量各项评分均高于对照组(P <0.05)。结论 CRT治疗CHF是基于右心室和左心室共同改善而发挥作用,术前右心室功能,尤其Tei指数是影响病人术后预后和生活质量的重要因素。 Objective To explore the effect of cardiac resynchronization therapy on the right ventricular function and the level of inflam -matory factors in patients with chronic heart failure.Methods:Eighty six patients with moderate or severe chronic heart failure who re -ceived resynchronization therapy in our hospital from June 2014 to June 2017,were followed up for 6 months.The patients whose NYHAgrading decreased by one grade or more,and the left ventricular end systolic volume decreased by over 15% were taken as the ob -servation group,and the remaining patients were the control group.Results:Sixty- two patients were included in the observation groupand 24 patients in the control group.Except for the Tei index, there were no significant differences in the general data and LVEDV,LVESV,LVEF,RVFAC,TAPSE,RIMP,Vsr,E peak,NYHA score,and inflammation related indexes between the two groups (P 〉0.05).LVEDV,LVESV,LVEF,and RIMP score were significantly decreased in the observation group (P 〈0.05),RVFAC,TAPSE,Vsr,and E peak weresignificantly increased (P 〈0.05).Compared with preoperation, there were no significant improvements in the indexes of the controlgroup (P 〉0.05).Compared with preoperation, the Tei index in the observation group decreased significantly,while the control groupincreased significantly (P 〈0.05).The expression levels of inflammatory factors (TNF- alpha,IL -6 and hs- CRP) in the two groupswere reduced to varying degrees,the improvement degree of the observation group was statistically significant (P 〈0.05),while that inthe control group had no statistically significant change ( P 〉0.05).The expression levels of inflammatory factors in the observationgroup were significantly lower than that in the control group ( P 〈0.05).The overall quality of life of the patients in the observationgroup was significantly higher than that in the control group (P 〈0.05).Conclusion CRT treatment of CHF disease is based on thecommon outcome of right ventricle and left ventricle.Preoperative right ventricular function,especially Tei,is an important factor that in -fluences postoperative prognosis and quality of life.
作者 邱凌峰 Qiu Lingfeng(Cardiology Department,The Armed Police Qinghai General Hospital,Xining 810000,Qinghai,China)
出处 《中西医结合心脑血管病杂志》 2018年第21期3155-3158,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 慢性心力衰竭 再同步治疗 右心室功能 炎症因子 生活质量 chronic heart failure cardiac resynchronization therapy right ventricular function inflammatory factors quality of life
  • 相关文献

参考文献10

二级参考文献99

  • 1刘尊齐,崔连群,王勇,许法运.血脂康对慢性心力衰竭患者心功能、血清C-反应蛋白和血脂的影响[J].中国中西医结合杂志,2007,27(3):220-222. 被引量:14
  • 2沈法荣,王志军,陈建明,黄抒伟,凌锋,俞尉,陈旭姣,吕锋,何仁良,夏瑜.心脏再同步化治疗中经胸心外膜起搏导线的植入技术[J].心电学杂志,2007,26(1):29-31. 被引量:3
  • 3郑莜萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.286.
  • 4李海洲,夏豪,王薇.游离血红蛋白及其受体CD163在大鼠动脉粥样硬化过程中的作用[J].中国病理生理杂志,2007,23(9):1695-1699. 被引量:11
  • 5无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3684
  • 6Drewes HW,Steuten LM,Lemmens LC,et al.The effectiveness of chronic care management for heart failure:meta-regression analyses to explain the heterogeneity in outcomes[J].Health Serv Res,2012,47(5):1926-59.
  • 7Stoiser B,Mtirtl D,Hiilsmann M,et al.Copeptin,a fragment of the vasopressin precursor,as a novel predictor of outconle in heart failure[J].Eur J Clin Invest,2006.36(11):771-778.
  • 8Neuhold S,Huelsmann M,Strunk G,et al.Comparison of copeptin,B-type natriuretic peptide,and aminoterminal pro-B-type natriuretic peptide in patients with chronic heart failure:prediction of death at different stages of the disease[J].J Am Coil Cardiol,2008,52(4):266-272.
  • 9Masson S,Latini R,Carbonieri E,et al.The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure:data from the GISSI-heart failure(GISSI-HF)trial[J].Eur J Hearl Fail,2010,12:338-347.
  • 10Alehagen U,Dablstrtim U,Rehfeld JF,et al.Association of copeptin and N-terminal pro BNP concentrations with risk of cardiovascular death in older patients with symptoms of heartfailure[J].JAMA,2011,305:2088-2095.

共引文献130

同被引文献65

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部